Filing Details
- Accession Number:
- 0001415889-25-015450
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-03 17:44:47
- Reporting Period:
- 2025-05-30
- Filing Date:
- 2025-06-03
- Accepted Time:
- 2025-06-03 17:44:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
856982 | Merit Medical Systems Inc | MMSI | Surgical & Medical Instruments & Apparatus (3841) | 870447695 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1564203 | David Floyd | 1600 West Merit Parkway South Jordan UT 84095 | No | No | No | No |
Transaction Summary
Sold: | 3,515 shares | Avg. Price: $94.16 | Total Value: $330,972.40 |
Number of Shares After Transactions: | 4,880 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Disposition | 2025-05-30 | 3,515 | $94.16 | 4,880 | No | 4 | S | Indirect | David K. Floyd Living Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | David K. Floyd Living Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, No Par Value | 1,584 | Indirect | David & Lisa Floyd Family LP |
Common Stock, No Par Value | 8,602 | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025
- The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.87 to $94.46, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.